None
NL
Sionna Therapeutics (NASDAQ:SION) Shares Down 5.1% After Insider Selling
['Defense World Staff']
Defense World
Sionna Therapeutics, Inc. (NASDAQ:SION – Get Free Report) fell 5.1% during trading on Wednesday after an insider sold shares in the company.
Get Sionna Therapeutics alerts:Specifically, Director Bruce Booth sold 12,388 shares of Sionna Therapeutics stock in a transaction that occurred on Tuesday, September 30th.
Also, Director Bruce Booth sold 66,105 shares of Sionna Therapeutics stock in a transaction that occurred on Monday, September 29th.
Sionna Therapeutics (NASDAQ:SION – Get Free Report) last issued its quarterly earnings results on Monday, August 11th.
See AlsoReceive News & Ratings for Sionna Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sionna Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.